No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Briotech Expands: Company Moves to a 82,000 SF Class-A Wesmar Building in Woodinville, Washington

Editor: What To Know

  • Through the support of their customers, commercial and financial partners, talented staff, and our ongoing shareholder support, the company has grown so quickly this year that we have moved twice—once in February, to a functionally 2x larger space, and again this fall to this 6x larger facility where we continue to increase HOCl production and bottling capacity for our personal care, and cleaning and disinfection product lines.
  • announced it has finalized its move into a new corporate office and manufacturing facility to support the growth in demand of Briotech’s line of Pure HOCl products.
  • In addition, the BrioWHISH Network Systems that we build here in Woodinville accommodate the production of millions of gallons per day, or more, on a global basis.

December 23, 2020

Briotech, Inc. announced it has finalized its move into a new corporate office and manufacturing facility to support the growth in demand of Briotech’s line of Pure HOCl products.

Briotech notes that in addition to its flagship product, Briotech Topical Skin Spray, the company produces Super Oxidized Saline for oral use, and an EPA approved Multi Surface Sanitizer + Disinfectant effective against coronavirus (the novel SARS-CoV-2 pandemic virus that causes COVID-19).

Through the support of their customers, commercial and financial partners, talented staff, and our ongoing shareholder support, the company has grown so quickly this year that we have moved twice—once in February, to a functionally 2x larger space, and again this fall to this 6x larger facility where we continue to increase HOCl production and bottling capacity for our personal care, and cleaning and disinfection product lines. In addition, the BrioWHISH Network Systems that we build here in Woodinville accommodate the production of millions of gallons per day, or more, on a global basis.” said Rick Lockett, CEO of the company.

BrioHOCl is composed of salt, water, and hypochlorous acid, and unlike bleach, quaternary ammonias, alcohol, or pH neutral HOCl, BrioHOCl boasts a safety profile that makes PPE (personal protective equipment) unnecessary, presents no skin or lung irritation risks, is non-flammable, is food-contact safe, and requires no rinsing or wiping. Briotech’s BrioWHISH Systems produce the world’s first pure HOCl to be manufactured at scale with zero contaminants or buffers that reduce the competing products efficacy, safety, and stability.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy